Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales
Open Access
- 25 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (2) , 353-358
- https://doi.org/10.1093/jac/dkp188
Abstract
This study aimed to investigate the origin of high-level azithromycin resistance that emerged in isolates of Neisseria gonorrhoeae in England and Wales in 2007, and to establish methods for identifying high-level azithromycin resistance. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) data from 2001–07 were examined for emerging trends in azithromycin susceptibility. Further to the identification of six high-level azithromycin-resistant isolates in GRASP 2007, an additional 102 isolates were selected on the basis of azithromycin susceptibility and geographic origin from the GRASP 2006 and 2007 collections. Susceptibility testing by Etest and disc diffusion was performed on all 108 isolates and 75 of these were typed by N. gonorrhoeae multiantigen sequence typing. A slight drift towards higher MICs of azithromycin was observed in the gonococcal population since 2001. Of greater concern was the first example of a shift to high-level resistance observed in six isolates in 2007. All six isolates were sequence type 649, which was not observed in any of the lower-level azithromycin-resistant isolates from 2007 or in any isolates tested from the same geographical locations. Contact tracing data for one patient suggested a link with Scotland. Disc diffusion testing of all 108 isolates showed that azithromycin, but not erythromycin, discs can differentiate between low-level and high-level resistance. High-level azithromycin resistance has emerged in England and Wales. Contact tracing and typing data suggest this may have originated from Scotland. Surveillance of azithromycin resistance will be key in controlling its further dissemination.Keywords
This publication has 18 references indexed in Scilit:
- Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in ScotlandJournal of Antimicrobial Chemotherapy, 2008
- Pharyngeal gonorrhoea – is dual therapy the way forward?International Journal of STD & AIDS, 2007
- Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: A prospective studyIndian Journal of Medical Microbiology, 2007
- In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeaeJournal of Infection and Chemotherapy, 2006
- Rapid Sequence‐Based Identification of Gonococcal Transmission Clusters in a Large Metropolitan AreaThe Journal of Infectious Diseases, 2004
- European guideline for the management of gonorrhoeaInternational Journal of STD & AIDS, 2001
- European guideline for the management of chlamydial infectionInternational Journal of STD & AIDS, 2001
- Azithromycin and erythromycin resistant Neisseria gonorrhoea e following treatment with azithromycinInternational Journal of STD & AIDS, 1997
- Multicenter Trial of Single-Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated GonorrheaSexually Transmitted Diseases, 1994
- Azithromycin in the treatment of sexually transmitted diseaseJournal of Antimicrobial Chemotherapy, 1990